Target Gene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Gene Today - Breaking & Trending Today

[Full text] LINC00184 promotes OC proliferation and cisplatin resistance


Yuwen Han, Jun You, Yun Han, Yinglei Liu, Menghui Huang, Xiaoyan Lu, Jingjing Chen, Yanli Zheng
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, People’s Republic of China
Correspondence: Yanli Zheng
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, No. 6 North Hai-Er-Xiang Road, Chongchuan District, Nantong, 226001, Jiangsu Province, People’s Republic of China
Tel +86-0513-85061000
Objective: Cisplatin resistance is one of the main reasons for treatment failure in ovarian cancer (OC). Here, the effects of LINC00184 on cisplatin-resistant OC were studied.
Patients and Methods: LINC00184, miR-1305 and CNTN1 expression in tissues from 70 OC patients was determined by qRT-PCR, in situ hybridization and Western blot. OC cell lines and OC cisplatin-resistant cell lines were cultured. Cells were transfected using Lipofectamine 2000 an ....

United States , United Kingdom , Eteläuomen Läi , Association Between , Laboratory Animals , Shanghai Institute Of Cell Biology , Qiagen Company , Chinese Academy Of Sciences Shanghai , Ambion Company , Second Affiliated Hospital Of Nantong University , Dnasei Qiagen Company , Shanghai Experimental Animal Center , Second Affiliated Hospital , Nantong University , Situ Hybridization , Shanghai Institute , Cell Biology , Thermo Fisher Scientific , Mountain View , Cell Quest , Dual Luciferase Reporter Assay System , Nanodrop Technologies , National Institutes , Health Guide , Chinese Academy , Santa Cruz ,

[Full text] LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZB


1
1Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Jiangxi Provincial Clinical Research Center for Vascular Anomalies, Basic Medical School, Gannan Medical University, Ganzhou, Jiangxi, 341000, People’s Republic of China;
2Basic Medical School, Gannan Medical University, Ganzhou, Jiangxi, 341000, People’s Republic of China;
3Department of Pediatric Surgery, Jiangxi Provincial Clinical Research Center for Vascular Anomalies, Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, The First Affiliate Hospital of Gannan Medical University, Ganzhou, Jiangxi, 341000, People’s Republic of China
These authors contributed equally to this work
Correspondence: Qian Liu ....

United States , United Kingdom , Eteläuomen Läi , Transwell Chamber Assay , Biosystems Inc , Shanghai Institute Of Biochemistry , Spss Inc , Hospital Of Gannan Medical University , Chinese Academy Of Sciences , World Medical Association Declaration Of Helsinki , Ethics Committee , Medical Ethics Committee , Gannan Medical , World Medical Association Declaration , Chinese Academy , Shanghai Institute , Cell Biology , Forma Scientific United Kingdom , Applied Biosystems , Santa Cruz , Synthgene Biotech , Dual Luciferase Reporter Assay , Breast Cancer Cells Proliferation , While Accelerating , Target Gene , Breast Cancer ,